A detailed history of Ninepoint Partners LP transactions in Mckesson Corp stock. As of the latest transaction made, Ninepoint Partners LP holds 1,201 shares of MCK stock, worth $631,653. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,201
Holding current value
$631,653
% of portfolio
0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$518.81 - $607.81 $623,090 - $729,979
1,201 New
1,201 $701,000
Q1 2023

May 04, 2023

BUY
$335.35 - $386.06 $181,424 - $208,858
541 Added 46.56%
1,703 $606,000
Q4 2022

Feb 01, 2023

BUY
$346.68 - $397.58 $402,842 - $461,987
1,162 New
1,162 $436,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Ninepoint Partners LP Portfolio

Follow Ninepoint Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninepoint Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ninepoint Partners LP with notifications on news.